Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2018

01-02-2018 | Research Article

Efficacy and feasibility of a collaborative multidisciplinary program for antibiotic prophylaxis in clean wound surgery

Authors: Xinyu Li, Hong Chen, Shenyin Zhu, Yu Liu, Jiadan Yang, Zhe Yuan, Gaoqun Yao, Feng Qiu

Published in: International Journal of Clinical Pharmacy | Issue 1/2018

Login to get access

Abstract

Background Despite national and international guidelines and recommendations, inappropriate prophylactic antibiotic use for clean wound surgery remains a common phenomenon in many Chinese hospitals, causing higher medical costs and bacterial resistance. Objective To improve the prescribing behavior for antibiotic prophylaxis and decrease antibiotic abuse and/or misuse in clean wound surgery. Setting The teaching hospital of a medical university in Southwest China. Methods A collaborative multidisciplinary program involving educational, technical, and administrative strategies was undertaken. It was characterized by a monthly evaluation by clinical pharmacists for randomly selected cases of clean wound surgery, as well as a group discussion attended by correlative personnel, consisting of the administrative staff, experts from the Rational Drug Use Committee, clinical pharmacists and surgeons. Main outcome measure The overall incidence of antibiotic prophylaxis, appropriate antibiotics selection, appropriate initial dosage timing, proper drug combination and the duration of antibiotic prophylaxis were measured. Results from 2009 to 2014, the rate of antibiotic prophylaxis for clean wound surgery declined from nearly 100% to 20–30%. Improvements were also observed in drug selection, timing of the first dose, and dosage and duration for antibiotic prophylaxis. Broad-spectrum antibiotics and enzyme inhibitors have seldom been used after 2011. The medical cost for antibiotics also decreased. Conclusion A collaborative multidisciplinary program, together with a group discussion, is efficient for improving rational antibiotic prophylaxis for clean wound surgery. This study indicates that clinical pharmacists can play a pivotal role in providing the professional evaluation of medical cases, education, and intervention.
Literature
1.
go back to reference Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.CrossRefPubMed Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.CrossRefPubMed
2.
go back to reference Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China—a major future challenge. Lancet. 2009;373:30.CrossRefPubMed Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China—a major future challenge. Lancet. 2009;373:30.CrossRefPubMed
3.
go back to reference Page CP, Bohnen JM, Fletcher JR, Mcmanus AT, Solomkin JS. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg. 1993;128:79–88.CrossRefPubMed Page CP, Bohnen JM, Fletcher JR, Mcmanus AT, Solomkin JS. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg. 1993;128:79–88.CrossRefPubMed
4.
go back to reference Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy. 33rd ed. Hyde Park, VT: Antimicrobial Therapy; 2003. Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy. 33rd ed. Hyde Park, VT: Antimicrobial Therapy; 2003.
5.
go back to reference Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 2013;70:195–283.CrossRefPubMed Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 2013;70:195–283.CrossRefPubMed
6.
go back to reference Bratzler Dale W, Houck Peter M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–15.CrossRefPubMed Bratzler Dale W, Houck Peter M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–15.CrossRefPubMed
7.
go back to reference Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 2008 SIGN publication; no. 104. Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 2008 SIGN publication; no. 104.
8.
go back to reference Zhang HX, Li X, Huo HQ, Liang P, Zhang JP, Ge WH. Pharmacist interventions for prophylactic antibiotic use in urological inpatients undergoing clean or clean-contaminated operations in a Chinese hospital. PLoS ONE. 2014;25:e88971.CrossRef Zhang HX, Li X, Huo HQ, Liang P, Zhang JP, Ge WH. Pharmacist interventions for prophylactic antibiotic use in urological inpatients undergoing clean or clean-contaminated operations in a Chinese hospital. PLoS ONE. 2014;25:e88971.CrossRef
9.
go back to reference He SP, Li ZL, Yan Q. Survey of the perioperative prophylactic use of antimicrobial agents in 118 hospitals in China. Zhonghua Wai Ke Za Zhi. 2008;46(1):12–4 [Article in Chinese].PubMed He SP, Li ZL, Yan Q. Survey of the perioperative prophylactic use of antimicrobial agents in 118 hospitals in China. Zhonghua Wai Ke Za Zhi. 2008;46(1):12–4 [Article in Chinese].PubMed
10.
go back to reference Zhou Y, Ma LY, Zhao X, Tian SH, Sun LY, Cui YM. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations. Int J Clin Pharmacol Ther. 2015;53:605–15.CrossRef Zhou Y, Ma LY, Zhao X, Tian SH, Sun LY, Cui YM. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations. Int J Clin Pharmacol Ther. 2015;53:605–15.CrossRef
11.
12.
go back to reference Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in sugery. Surg Infect(Larchmt). 2013;13:73.CrossRef Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in sugery. Surg Infect(Larchmt). 2013;13:73.CrossRef
13.
go back to reference Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2012;10:73-78. Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2012;10:73-78.
14.
go back to reference Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101:2916.CrossRefPubMed Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101:2916.CrossRefPubMed
15.
go back to reference Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, et al. Workforce on evidence-based medicine, society of thoracic surgeons. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007;83(4):1569–76.CrossRefPubMed Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, et al. Workforce on evidence-based medicine, society of thoracic surgeons. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007;83(4):1569–76.CrossRefPubMed
16.
go back to reference Narkbunnam R, Chareancholvanich K. Causes of failure in total knee arthroplasty. J Med Assoc Thai. 2012;95(5):667–73.PubMed Narkbunnam R, Chareancholvanich K. Causes of failure in total knee arthroplasty. J Med Assoc Thai. 2012;95(5):667–73.PubMed
17.
go back to reference Ponce B, Raines BT, Reed RD. Surgical site infection after arthroplasty: comparative effectiveness of prophylactic antibiotics: do surgical care improvement project guidelines need to be updated? J Bone Joint Surg Am. 2014;96(12):970–7.CrossRefPubMed Ponce B, Raines BT, Reed RD. Surgical site infection after arthroplasty: comparative effectiveness of prophylactic antibiotics: do surgical care improvement project guidelines need to be updated? J Bone Joint Surg Am. 2014;96(12):970–7.CrossRefPubMed
Metadata
Title
Efficacy and feasibility of a collaborative multidisciplinary program for antibiotic prophylaxis in clean wound surgery
Authors
Xinyu Li
Hong Chen
Shenyin Zhu
Yu Liu
Jiadan Yang
Zhe Yuan
Gaoqun Yao
Feng Qiu
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0576-6

Other articles of this Issue 1/2018

International Journal of Clinical Pharmacy 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.